Xense.one

Xense.one

Share

uTomo
Personalized All-in-One X-ray Tomography

Minimize Time to Diagnosis
Minimize Time to Treatment
Minimize Time to Wellness

Over 20 patents have been filed on uTomo & related inventions worldwide
*uTomo based products are not yet FDA approved.

01/27/2025

What is the impact of XENSE META CT on clinics/hospitals, healthcare organizations and patients?
LEARN more details about our impact πŸ‘‡
https://www.startengine.com/offering/xense
Meta β„’ CT is under development and not yet FDA-approved.
, , , ,

01/20/2025

What is the impact of XENSE META CT on clinics/hospitals, healthcare organizations and patients?

LEARN more details about our impact πŸ‘‡
https://www.startengine.com/offering/xense

Meta β„’ CT is under development and not yet FDA-approved.

, , , ,

12/02/2024

A Smarter, Safer Future by Metaβ„’ CT.
XENSE is transforming medical imaging to enable safer, more efficient solutions for healthcare delivery.
Discover our impact on StartEngine today! Link in bio. πŸ‘†
Meta β„’ CT is not yet FDA approved and is under development.
, , , ,

11/07/2022

According to the article, published in in 2007, "about 0.4% of all cancers in the United States may be attributable to the radiation from CT studies." Further, based on subsequent increases in CT usage, "this estimate might now be in the range of 1.5-2.0%." This estimated risk is heavily dependent on age at time of exposure, the risk being much higher in younger patients, especially children. This reflects both a greater sensitivity to radiation effects in younger patients and a longer expected lifespan during which cancer can develop.

Want your practice to be the top-listed Clinic in Irvine?
Click here to claim your Sponsored Listing.

Telephone

Address


Irvine, CA
92618